Theme Member
Dr Sally Martin

Contact Details

Phone: 8128 4694

Email: sally.martin@adelaide.edu.au

https://www.researchgate.net/profile/Sally_Martin2

Qualifications:

Doctorate of Philosophy, conferred 3rd August 2009, Department of Medicine, University of Adelaide, Adelaide.

Bachelor of Medical and Pharmaceutical Biotechnology (Honours), conferred 12th April 2005, Division of Health Sciences, University of South Australia, Adelaide.

Biography/Research Focus

In recent years, our laboratory has demonstrated that the PI3K and mTOR pathways are crucial regulators of bone remodelling both in vitro and in vivo, and that chemical inhibitors of these pathways are potential treatments for patients afflicted with skeletal fragility (eg. osteoporosis, tumour-associated bone loss). My current research is focussed on extending these findings and examining (i) the role of the mTOR signalling pathways in mesenchymal stem cell biology, (ii) the role of the mTOR signalling pathways in regulating skeletal biology and bone remodelling, and (iii) the role of skeletal mTOR signalling in regulating systemic glucose metabolism.

Publications

  1. Forristal C.E., Brown A., Helwani F.M., Winkler I.G., Nowlan B., Powell J., Engler G., Diakiw S.M., Zannettino A.C.W., Martin, S.K., Pattabiraman D., DÁndrea R., Lewis I., Levesque J.P. Hypoxia inducible factor (HIF-2a) enhances proliferation of malignant hematopoietic cells and disease progression in the hypoxic malignant bone marrow. Manuscript accepted, Leukemia.
  2. Cheong, C.M., Chow, A.W., Fitter, S., Hewett, D.R., Martin, S.K., Williams, S.A., To, L.B., Zannettino, A.C.W., and Vandyke, K. (2015). Tetraspanin 7 (TSPAN7) regulates multiple myeloma cell transendothelial migration and adhesion. Experimental Cell Research. 332(1): 24-38.
  3. Martin, S.K, Dutta, A.K., Matthews, M.P., Fitter, S., and Zannettino, A.C.W. (2015) The differential roles of mTORC1 and mTORC2 in mesenchymal stem cell differentiation. Stem Cells. doi: 10.1002/stem.1931. Epub ahead of print.
  4. Martin, S.K, Gan, Z.Y., Fitter, S., and Zannettino, A.C.W. (2015). The effect of the PI3K inhibitor, NVP-BKM120, on myeloma tumour growth and bone remodelling. Leukemia Research. 39(3): 380-387.
  5. Gan, Z.Y., Fitter, S., Vandyke, K., Zannettino, A.C.W., and Martin, S.K. (2014) The effect of the dual PI3K and mTOR inhibitor, NVP-BEZ235, on myeloma tumour growth and bone remodelling. European Journal of Haematology, doi: 10.1111/ejh.12436. Epub ahead of print.
  6. Martin, S.K., Diamond, P., Gronthos, S., Peet, D.J., and Zannettino, A.C.W. (2011) The emerging role of hypoxia, HIF-1 and HIF-2 in multiple myeloma. Leukemia, 25(10): 1533-1542.
  7. Williams, S.A.*, Martin, S.K.*, Vincent, C., Gronthos, S., Zheng, T., Atkins, G.J., and Zannettino, A.C.W. (2010) Circulating levels of TWEAK correlate with bone erosion in multiple myeloma patients. British Journal of Haematology, 150(3): 373-376.
  8. Martin, S.K.*, Fitter, S.*, Bong, L.F., Drew, J., Gronthos, S., Shepherd, P., and Zannettino, A.C.W. (2010) NVP-BEZ235, a dual pan class I PI3 kinase and mTOR inhibitor, promotes osteogenic differentiation of human mesenchymal stromal cells. Journal of Bone and Mineral Research, 25(10):2126-2137
  9. Psaltis, P.J., Paton, S., See, F., Arthur, A., Martin, S.K., Itescu, S., Worthley, S.G., Gronthos, S., and Zannettino, A.C.W. (2010) Enrichment for STRO-1 expression enhances the cardiovascular paracrine activity of human bone marrow-derived mesenchymal cell populations. Journal of Cellular Physiology, 223(2):530-540
  10. Martin, S.K., Diamond, P., To, L.B., Peet, D.J., Gronthos, S., and Zannettino, A.C.W. (2010) Hypoxia-inducible factor-2 is a novel regulator of aberrant CXCL12 expression in multiple myeloma plasma cells. Haematologica, 95(5):776-784.

Awards/Funding

Awards

Mary Overton Early Career Research Fellowship, May 2012-May 2015, Royal Adelaide Hospital Research Committee.

Early Career Investigator Award, June 2012, Centre for Cancer Biology, SA Pathology, Adelaide.

Best Stem Cell Paper, December 2010, Centre for Stem Cell Research, University of Adelaide, Adelaide.

University Doctoral Research Medal, April 2010, University of Adelaide, Adelaide

Albert Baikie Medal, October 2009, Haematological Society of Australia and New Zealand.

Postgraduate Travelling Fellowship, June 2007, University of Adelaide, Adelaide.

Australian Postgraduate Award Scholarship, March 2005-September 2008, University of Adelaide, Adelaide.

Winifred S. Steele Scholarship, March 2005-March 2008, University of Adelaide, Adelaide.

Funding

Centre for Stem Cell Research Project Grant 2012, The role of raptor and rictor in MSC differentiation, AUD$75,000

Novartis Pharmaceuticals Project Grant 2011, Can the dual PI3K/mTOR inhibitor NVP-BEZ235 be used to stimulate bone formation in multiple myeloma? AUD$75,000.

Get in touch
+61 8 8128 4000 info@sahmri.com
You can't miss us!
North Terrace Adelaide 5000 South Australia
Postal Address
PO BOX 11060 Adelaide 5001 South Australia
Key Partners
SAHMRI is located on the traditional lands of the Kaurna Nation.

The SAHMRI community acknowledges and respects the traditional owners, the family clans who are the Kaurna Nation from the Adelaide Plains region of South Australia. We acknowledge the clans of the Kaurna Nation and the sacred knowledge they hold for their country. We pay our respects to the Kaurna Nation, their ancestors and the descendants of these living family clans today.